• Delivers five billion bacteria in each chewable tablet
• Utilizes the LiveBac tableting process to ensure viability of the bacteria
• Promotes healthy immune system functions
• Provides good bacteria to help maintain optimal bacterial balance
• Provides beneficial bacteria to promote healthy digestion
• Promotes stomach comfort and bowel regularity
• Supports healthy digestive functions
• Supports healthy teeth and gums
• Contains five unique bacterial strains
  
• Streptococcus salivarius
• Lactobacillus rhamnosus
• Lactobacillus salivarius
• Lactobacillus paracasei
• Lactobacillus plantarum

* LiveBac® is a registered trademark of Probi USA, Inc. in the USA.

Research has shown that probiotics have a positive impact on immunity, digestive health and much more. Probiotics help maintain a healthy balance of bacteria in the gastrointestinal tract and are increasingly important in the Asian diet as we continue to rely on processed foods and prescription medications.

Streptococcus salivarius
S. salivarius populates in the upper respiratory tract of healthy infants within first few hours of birth. This is the primary bacterium in the human oral cavity, oropharynx and upper respiratory tract. S. salivarius can help to reduce dental plaque, supporting healthy gums and teeth.

Lactobacillus rhamnosus
L. rhamnosus is a strain of probiotics that aids in balancing the microflora in the digestive tract. It is one of the most intensely studied bacteria. One of the remarkable things about L. rhamnosus is its ability to tolerate and even thrive in the harsh acidic conditions normally found in the stomach. L. rhamnosus has been shown to support immune functions and digestive health.

Lactobacillus salivarius
L. salivariusresides can be found in the mouth and small intestine. It has been shown to be effective in minimizing unhealthy bacteria in the mouth, thus promoting dental health. L. salivarius may also support immune health.

Lactobacillus paracasei
Like other lactobacillus species, L. paracasei is acid and bile resistant. This aids in the bacteria’s ability to travel from the mouth, through the stomach and finally into the intestine while still remaining viable. L. paracasei and L. rhamnosus have the ability to survive in the acidic conditions of the stomach. Probiotics like L. paracasei are able to create acidic environments that promote bacterial balance.

Lactobacillus plantarum
L. plantarum promotes healthy digestive system functions by promoting bacterial balance and by competing for nutrients with unhealthy bacteria which may be present. Another amazing talent of L. plantarum is its ability to synthesize L-lysine, an essential amino acid which is required for several functions in the body.

Can DNA Miracles Chewable Probiotics be taken with other Isotonix products or DNA Miracles Isotonix OPC-3®?
Yes. DNA Miracles Chewable Probiotics can safely be taken with other Isotonix products, provided one follows the recommended serving size for each product. DNA Miracles Isotonix OPC-3 can also be taken with DNA Miracles Chewable Probiotics.

How should I take DNA Miracles Chewable Probiotics?
As a health food prior to the first meal of the day, chew 1 tablet or allow to melt in mouth, or take as directed by your healthcare provider.

Are there any allergens in DNA Miracles Chewable Probiotics?
DNA Miracles Chewable Probiotics contains trace amounts of milk from the fermentation process. There are less than 2 parts per million (ppm) of milk in each serving. This product is safe for individuals with lactose sensitivity.

How long will it take before this product begins to support my child’s digestive needs after taking DNA Miracles Chewable Probiotics?
Each child is different, depending on their gastrointestinal tract and sensitivity also varies from child to child. In some cases, support will begin within a few days. In others, it may take weeks.

How will DNA Miracles Chewable Probiotics affect digestion?
There are many aspects to good digestion. They include enzymes (which start breaking down foods in the mouth and are found in the intestines), pH conditions, bile from the gall bladder, intestinal microflora and some digestive properties contained in the food that we eat. Diet and supplementing your intestines with probiotics can help support digestion. Well balanced intestinal micro flora will promote healthy digestive system functions.

What is LiveBac™*, and why is it important?
Probiotics are live microorganisms and must remain live while bottled and when ingested in order to be effective in the digestive tract. However, as sensitive organisms, many probiotics in many products die off quickly when bottled. Furthermore, many probiotics die during the digestive process before reaching the large intestine because of the harshly acidic environment in the stomach. LiveBac is a patented technology which protects the bacteria to help ensure that they stay alive and protected so they are optimally functional in the digestive tract.

*LiveBac® is a registered trademark of Probi USA, Inc. in the USA.

Can children under age two take DNA Miracles Chewable Probiotics?
No, this product is recommended for ages two and older. There is conflicting research as to when a child’s own probiotic microflora is determined (one or two years of age). Taking this type of product before age two could influence this natural process. It’s better for a child to establish his/her own initial gut flora from foods and the general environment.

Is DNA Miracles Chewable Probiotics safe?
DNA Miracles Chewable Probiotics is safe and free of harmful agents. The product is made in the United States in FDA-inspected facilities using Good Manufacturing Practices. Customers can have confidence in the quality and safety of this product.

• Bekkali, N., et al. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study. Nutrition Journal. 6: 17, 2007.
• Broekaert, I. and Walker, A. Probiotics and Chronic Disease. Journal of Clinical Gastroenterology. 40(3): 270-274, 2006.
• Brudnak, M. Probiotics as an adjuvant to detoxification protocols. Medical Hypotheses. 58(5): 382-385, 2002.
• Fernandes, C., et al. Control of diarrhea by lactobacilli. Journal of Applied Nutrition. 40: 32-43, 1988.
• Friedrich, M. A bit of culture for children: probiotics may improve health and fight disease. Journal of the American Medical Association. 284(11): 1365-1366, 2000.
• Frohmader, T., et al. Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial. American Journal of Critical Care. 19: 1-11, 2010.
• Gill, H. and Guarner, F. Probiotics and human health: a clinical perspective. Postgraduate Medical Journal. 80(947): 516-526, 2004.
• Guarner, F. and Malagelada, J. Gut flora in health and disease. Lancet. 361(9356): 512-519, 2003.
• Ljungh, Å., et al. Isolation, selection and characteristics of Lactobacillus paracasei subsp. paracasei F19. Microbial Ecology in Health and Disease. 3: 4-6, 2002.
• Marteau, P., et al. Protection from gastrointestinal diseases with the use of probiotics. American Journal of Clinical Nutrition. 73(Suppl): 430S-436S, 2001.
• Parracho, H., et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. Journal of Medical Microbiology. 54: 987-991, 2005.
• Roberfroid, M. Prebiotics and probiotics: are they functional foods? American Journal of Clinical Nutrition. 71(Suppl): 1682S-1687S, 2000.
• Rolfe, R. The role of probiotic cultures in the control of gastrointestinal health. Journal of Nutrition. 130: 396S-402S, 2000.
• Szajewska, H. and Mrukowicz, J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. Journal of Pediatric Gastroenterology and Nutrition. 33: S17-S25, 2001.
• Van Niel, W., et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 109(4): 678-683, 2002.
• Wullt, M., et al. Lactobacillus plantarum 299v enhances the concentrations of fecal short chain fatty acids in patients with recurrent Clostridum difficile-associated diarrhea. Digestive Diseases and Sciences. 52: 2082-2086, 2007.